article Open AccessTop 1% cited
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Cancer Cell · 2011 · Vol. 19(1) · pp. 17–30
Wei Xu✉(Shanghai Medical College of Fudan University)Hui Yang(Shanghai Medical College of Fudan University)Ying Liu(Shanghai Medical College of Fudan University)Ying Yang(Fudan University)Ping Wang(Shanghai Medical College of Fudan University)Se Hee Kim(University of North Carolina at Chapel Hill)Shinsuke Ito(University of North Carolina at Chapel Hill)Yang Chen(Chinese Academy of Sciences)Pu Wang(Shanghai Medical College of Fudan University)Meng-Tao Xiao(Shanghai Medical College of Fudan University)Li-xia Liu(Shanghai Medical College of Fudan University)Wen-qing Jiang(Shanghai Medical College of Fudan University)Jing Liu(Chinese Academy of Sciences)Jin-ye Zhang(Shanghai Medical College of Fudan University)Bin Wang(Shanghai Medical College of Fudan University)Stephen V. Frye(University of North Carolina at Chapel Hill)Yi Zhang(University of North Carolina at Chapel Hill)Yan-hui Xu(Fudan University)Qun‐Ying Lei(Shanghai Medical College of Fudan University)Kun‐Liang Guan(Shanghai Medical College of Fudan University)Shimin Zhao(Shanghai Medical College of Fudan University)Yue Xiong(University of North Carolina at Chapel Hill)
Glioma Diagnosis and TreatmentHistone Deacetylase Inhibitors ResearchEpigenetics and DNA MethylationIDH2HistoneEpigeneticsIDH1BiologyHistone methylationCancer researchDemethylaseDNA methylationDNA demethylation
MeSH terms
AnimalsBinding, CompetitiveCytosineDNA-Binding ProteinsGliomaGlutaratesHistonesHumansMixed Function OxygenasesIsocitrate DehydrogenaseKetoglutaric AcidsModels, MolecularOxalatesOxidoreductases, N-DemethylatingProcollagen-Proline Dioxygenase
Citations
2,803
FWCI
84.56
field-weighted impact
References
56
Percentile
100%
vs. same field & year
Citations per year
Cited by
Fundamentals of cancer metabolism
Science Advances · 2016 · 2,929 citations
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers
Oncotarget · 2011 · 435 citations
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Blood · 2017 · 1,447 citations
Mitochondrial TCA cycle metabolites control physiology and disease
Nature Communications · 2020 · 2,577 citations
Otto Warburg's contributions to current concepts of cancer metabolism
Nature reviews. Cancer · 2011 · 3,376 citations
The Emerging Hallmarks of Cancer Metabolism
Cell Metabolism · 2016 · 5,806 citations
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
Cell Reports · 2017 · 606 citations
Mitochondrial Dysfunction in Cancer
Frontiers in Oncology · 2013 · 509 citations
References
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor
Genes & Development · 2002 · 1,520 citations
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Cancer Cell · 2010 · 1,966 citations
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Cancer Cell · 2005 · 2,043 citations
TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)
Leukemia · 2003 · 418 citations
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Cancer Cell · 2010 · 2,713 citations
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Cancer Cell · 2010 · 2,346 citations
IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
American Journal Of Pathology · 2009 · 1,020 citations
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
Cell · 1997 · 4,485 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
